Maternal vitamin B12 status and risk of neural tube defects in a population with high neural tube defect prevalence and no folic acid fortification

Pediatrics

Volumn 123, Issue 3, 2009, Pages 917-923

  Molloy, Anne M ^a,f   Kirke, Peadar N ^c   Troendle, James F ^d   Burke, Helen ^c   Sutton, Marie ^c   Brody, Lawrence C ^e   Scott, John M ^b   Mills, James L ^d  

^a Trinity Biomedical Sciences Institute   (Ireland)

^b TRINITY COLLEGE DUBLIN   (Ireland)

^c HEALTH RESEARCH BOARD   (Ireland)

^d EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^e NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

^f TRINITY COLLEGE DUBLIN   (Ireland)

Author keywords

Cobalamin; Folate; Folic acid fortification; Neural tube defects; Vitamin b 12

Indexed keywords

CYANOCOBALAMIN; FOLIC ACID;

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; GESTATIONAL AGE; HUMAN; IRELAND; MAJOR CLINICAL STUDY; NEURAL TUBE DEFECT; PREGNANCY; PREVALENCE; PRIORITY JOURNAL; RISK ASSESSMENT; VITAMIN BLOOD LEVEL; VITAMIN SUPPLEMENTATION; BLOOD; CASE CONTROL STUDY; COHORT ANALYSIS; CROSS-SECTIONAL STUDY; CYANOCOBALAMIN DEFICIENCY; NEWBORN; PREGNANCY COMPLICATION; PRENATAL CARE; RECURRENT DISEASE; RISK; SECOND TRIMESTER PREGNANCY;

ADULT; CASE-CONTROL STUDIES; COHORT STUDIES; CROSS-SECTIONAL STUDIES; FEMALE; FOLIC ACID; HUMANS; INFANT, NEWBORN; IRELAND; NEURAL TUBE DEFECTS; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY TRIMESTER, SECOND; PRENATAL CARE; RECURRENCE; RISK; VITAMIN B 12; VITAMIN B 12 DEFICIENCY; YOUNG ADULT;

EID: 63149166599     PISSN: 00314005     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.2008-1173     Document Type: Article

References (51)

1. MRC Vitamin Study Research Group. Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. Lancet. 1991;338(8760):131-137
2. Czeizel AE, Dudas I. Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation. N Engl J Med. 1992;327(26):1832-1835
3. Berry RJ, Li Z, Erickson JD, et al. Prevention of neural-tube defects with folic acid in China: China-U.S. Collaborative Project for Neural Tube Defect Prevention. N Engl J Med. 1999; 341(20):1485-1490
4. Honein MA, Paulozzi LJ, Mathews TJ, Erickson JD, Wong LY. Impact of folic acid fortification of the US food supply on the occurrence of neural tube defects. JAMA. 2001;285(23): 2981-2986
5. Mills JL, Signore C. Neural tube defect rates before and after food fortification with folic acid. Birth Defects Res A Clin Mol Teratol. 2004;70(11):844-845
6. Ray JG, Meier C, Vermeulen MJ, Boss S, Wyatt PR, Cole DE. Association of neural tube defects and folic acid food fortification in Canada. Lancet. 2002;360(9350):2047-2048
7. Persad VL, Van den Hof MC, Dube JM, Zimmer P. Incidence of open neural tube defects in Nova Scotia after folic acid fortification. CMAJ. 2002;167(3):241-245
8. Liu S, West R, Randell E, et al. A comprehensive evaluation of food fortification with folic acid for the primary prevention of neural tube defects. BMC Pregnancy Childbirth. 2004;4(1):20
9. Lopez-Camelo JS, Orioli IM, da Graca Dutra M, et al. Reduction of birth prevalence rates of neural tube defects after folic acid fortification in Chile. Am J Med Genet A. 2005;135(2):120-125
10. Williams LJ, Rasmussen SA, Flores A, Kirby RS, Edmonds LD. Decline in the prevalence of spina bifida and anencephaly by race/ethnicity: 1995-2002. Pediatrics. 2005;116(3):580-586
11. Brent RL, Oakley GP Jr, Mattison DR. The unnecessary epidemic of folic acid-preventable spina bifida and anencephaly. Pediatrics. 2000;106(4):825-827
12. Brent RL, Oakley GP Jr. Triumph and/or tragedy: the present Food and Drug Administration program of enriching grains with folic acid. Pediatrics. 2006;117(3):930-932
13. Brent RL, Oakley GP Jr. The Food and Drug Administration must require the addition of more folic acid in "enriched" flour and other grains. Pediatrics. 2005;116(3):753-755
14. Werler MM, Louik C, Shapiro S, Mitchell AA. Prepregnant weight in relation to risk of neural tube defects. JAMA. 1996; 275(14):1089-1092
15. Watkins ML, Rasmussen SA, Honein MA, Botto LD, Moore CA. Maternal obesity and risk for birth defects. Pediatrics. 2003; 111(5 pt 2):1152-1158
16. Waller DK, Mills JL, Simpson JL, et al. Are obese women at higher risk for producing malformed offspring? Am J Obstet Gynecol. 1994;170(2):541-548
17. Mills JL, McPartlin JM, Kirke PN, et al. Homocysteine metabolism in pregnancies complicated by neural-tube defects. Lancet. 1995;345(8943):149-151
18. Steegers-Theunissen RP, Boers GH, Trijbels FJ, Eskes TK. Neural-tube defects and derangement of homocysteine metabolism. N Engl J Med. 1991;324(3):199-200
19. 12 and anencephaly. Lancet. 1980;1(8173):880
20. 12 are independent risk factors for neural tube defects. Q J Med. 1993;86(11):703-708
21. 12, total plasma homocysteine and mutation of reductase [in Chinese]. Zhonghua Yu Fang Yi Xue Za Zhi. 2000;34(1):22-24
22. 12 and the risk of neural tube defects in a folic-acid-fortified population. Epidemiology. 2007;18(3):362-366
23. 12 and the risk of fetal neural tube defects in Egyptian patients. Clin Lab. 2007;53(1-2):69-75
24. 12, folate and homocysteine and the risk of neural tube defects in the offspring in a high-risk area of China. Public Health Nutr. 2008; In press 25. Wright ME. A case-control study of maternal nutrition and neural tube defects in Northern Ireland. Midwifery. 1995;11(3): 146-152
25. 12 levels and risk for neural tube defects in a Texas-Mexico border population. Ann Epidemiol. 2003;13(2):81-88
26. 12 status increases the risk of offspring with spina bifida. Am J Obstet Gynecol. 2004;191(1):11-17
27. 12 and transcobalamins in neural tube defects. Clin Genet. 1988;33(6):441-448
28. 12 and folate levels associated with neural tube defects. Am J Perinatol. 1998;15(9):511-514
29. 12 concentrations in maternal and fetal blood, and amniotic fluid in second trimester pregnancies complicated by neural tube defects. Br J Obstet Gynaecol. 1992;99(1):23-25
30. 12) in amniotic fluid. Prenat Diagn. 1998;18(6):545-555
31. Weekes EW, Tamura T, Davis RO, et al. Nutrient levels in amniotic fluid from women with normal and neural tube defect pregnancies. Biol Neonate. 1992;61(4):226-231
32. Murphy JF. Drugs and pregnancy. Ir Med J. 1984;77(2):52-56
33. 12 concentrations in pregnancies associated with neural tube defects. Arch Dis Child. 1985;60(7): 660-665
34. Daly LE, Kirke PN, Molloy A, Weir DG, Scott JM. Folate levels and neural tube defects. Implications for prevention. JAMA. 1995;274(21):1698-1702
35. Cotter AM, Molloy AM, Scott JM, Daly SF. Elevated plasma homocysteine in early pregnancy: a risk factor for the development of severe preeclampsia. Am J Obstet Gynecol. 2001; 185(4):781-785
36. Cotter AM, Molloy AM, Scott JM, Daly SF. Elevated plasma homocysteine in early pregnancy: a risk factor for the development of nonsevere preeclampsia. Am J Obstet Gynecol. 2003; 189(2):391-394
37. Eastern Regional Health Authority. Congenital Anomalies in the Eastern Region of Ireland 1980-1999. Report of the Dublin EURO-CAT Registry on Twenty Years of Congenital Anomaly Surveillance. Dublin, Ireland: Eastern Regional Health Authority; 2001
38. Kirke PN, Daly LE, Elwood JH. A randomised trial of low dose folic acid to prevent neural tube defects. The Irish Vitamin Study Group. Arch Dis Child. 1992;67(12):1442-1446
39. Murphy MM, Molloy AM, Ueland PM, et al. Longitudinal study of the effect of pregnancy on maternal and fetal cobalamin status in healthy women and their offspring. J Nutr. 2007;137(8):1863-1867
40. Milman N, Byg KE, Bergholt T, Eriksen L, Hvas AM. Cobalamin status during normal pregnancy and postpartum: a longitudinal study comprising 406 Danish women. Eur J Haematol. 2006;76(6):521-525
41. Cole BF, Baron JA, Sandler RS, et al. Folic acid for the prevention of colorectal adenomas: a randomized clinical trial. JAMA. 2007;297(21):2351-2359
42. 12 intake and cognitive decline among community-dwelling older persons. Arch Neurol. 2005;62(4):641-645
43. Troen AM, Mitchell B, Sorensen B, et al. Unmetabolized folic acid in plasma is associated with reduced natural killer cell cytotoxicity among postmenopausal women. J Nutr. 2006; 136(1):189-194
44. Herbert V, Bigaouette J. Call for endorsement of a petition to the Food and Drug Administration to always add vitamin B-12 to any folate fortification or supplement. Am J Clin Nutr. 1997; 65(2):572-573
45. Oakley GP Jr. Let's increase folic acid fortification and include vitamin B-12. Am J Clin Nutr. 1997;65(6):1889-1890
46. Pfeiffer CM, Caudill SP, Gunter EW, Osterloh J, Sampson EJ. Biochemical indicators of B vitamin status in the US population after folic acid fortification: results from the National Health and Nutrition Examination Survey 1999-2000. Am J Clin Nutr. 2005;82(2):442-450
47. 12 levels in the United States. Am J Clin Pathol. 1987;88(1):95-97
48. Pfeiffer CM, Johnson CL, Jain RB, et al. Trends in blood folate and vitamin B-12 concentrations in the United States, 1988 2004. Am J Clin Nutr. 2007;86(3):718-727
49. Knight EM, Spurlock BG, Edwards CH, et al. Biochemical profile of African American women during three trimesters of pregnancy and at delivery. J Nutr. 1994;124(6 suppl): 943S-953S
50. 12 insufficiency and the risk of fetal neural tube defects. QJM. 2003;96(4):289-295
51. Mills JL, Tuomilehto J, Yu KF, et al. Maternal vitamin levels during pregnancies producing infants with neural tube defects. J Pediatr. 1992;120(6):863-871.